Sorry, you need to enable JavaScript to visit this website.
Skip to main content

Our Management

Location Settings

Asia-Pacific

AU -  Sydney
AU -  Melbourne
AU -  Brisbane
CN -  Hong Kong
CN -  Shanghai
IN -  Bangalore
MY -  Kuala Lumpur
PH -  Metro Manila
KR -  Seoul
CN -  Taipei City
TH -  Bangkok
NZ -  New Zealand

North America

US -  San Francisco
US -  Boston

GLOBAL

English

SOLUTIONS

RESOURCES

ABOUT US

Location Settings

Asia-Pacific

AU -  Sydney
AU -  Melbourne
AU -  Brisbane
CN -  Hong Kong
CN -  Shanghai
IN -  Bangalore
MY -  Kuala Lumpur
PH -  Metro Manila
KR -  Seoul
CN -  Taipei City
TH -  Bangkok
NZ -  New Zealand

North America

US -  San Francisco
US -  Boston

GLOBAL

English

Board OF DIRECTORS

Joel Thickins

Joel Thickins

Chairman
Joel Thickins

Joel Thickins

Chairman

Joel is a Partner at TPG Capital and leads the firm’s investment program in the ANZ region as Head of Australia and New Zealand. Joel also currently sits on the Board of Inghams Group Limited and has served on the Boards of Accolade Wines, Gerard Lighting, Blue Star Print Group and Centric Wealth.

Dr. Fred Cohen

Dr. Fred Cohen

Board Member
Dr. Fred Cohen

Dr. Fred Cohen

Board Member

Fred Cohen is a Senior Advisor to TPG and was a Partner and co-founder of TPG Biotechnology. Fred has served on the Board of several biotech and pharmaceutical organizations including Biocryst (BCRX), CareDx (CDNA), […] and is a co-founder of Sweetwater Spectrum, a non-profit autism support organization.

 Vinnie Wong

Vinnie Wong

Board Member
 Vinnie Wong

Vinnie Wong

Board Member

Vincent Wong is with TPG Capital and is based in Melbourne, where he works in TPG’s Australian team. Prior to joining TPG in 2011, Vincent served in the Investment Banking Department at Goldman, Sachs & Co. Vincent graduated from The University of Melbourne with BCommerce and BLaws (Honors).

 Lydia Cai

Lydia Cai

Board Member
 Lydia Cai

Lydia Cai

Board Member

Lydia Cai is a Principal at TPG Capital Asia based in Beijing and leads TPG’s healthcare investments in the Greater China area. Prior to joining TPG in 2011, Lydia was an Associate at HAO Capital, a China-focused early stage private equity fund focusing on growth-stage healthcare investments.

Fiona Pak Poy

Fiona Pak Poy

Board Member
Fiona Pak Poy

Fiona Pak Poy

Board Member

Fiona currently serves as a non-executive director for Novotech, Isentia, Tyro Payments, Booktopia and the Sydney School of Entrepreneurship. She is a member of the Australian Government’s Innovation and Science Biomedical Translation Fund (BTF) committee. She has also served on MYOB, PageUp People, the Securities Industry Research Centre of South-East Asia and the federal Government board of Innovation Australia.

John Moller

John Moller

Chief Executive Officer
John Moller

John Moller

Chief Executive Officer

John joined Novotech in January 2014 to lead the development of Novotech’s Asia operations. Prior to Novotech John was Managing Director of IVF Australia and Queensland Fertility Group and sat on the Board of the parent company Virtus Health. John is a medical doctor by training.

Veronica Holloway

Veronica Holloway

Chief Legal and Compliance Officer
Veronica Holloway

Veronica Holloway

Chief Legal and Compliance Officer

Veronica joined Novotech in May 2014 to formalise the legal function at Novotech. Prior to Novotech, Veronica held roles as Senior Legal Counsel at EY, Senior Solicitor at Clayton Utz and General Counsel (on secondment) at Novartis Pharmaceuticals Australia Pty Limited. Veronica holds a BA/LLB/LLM.

Executive Management

John Moller

John Moller

Chief Executive Officer
John Moller

John Moller

Chief Executive Officer

John joined Novotech in January 2014 to lead the development of Novotech’s Asia operations. Prior to Novotech John was Managing Director of IVF Australia and Queensland Fertility Group and sat on the Board of the parent company Virtus Health. John is a medical doctor by training.

Michael stibilj

Michael stibilj

Chief Operating Officer
Michael stibilj

Michael stibilj

Chief Operating Officer

Michael has 25 years of experience in the CRO Industry. Prior to joining Novotech in 2017, Michael spent 15 years building and leading operations across Asia for Quintiles/IQVIA, and was senior advisor for TPG Capital.

Zidong Zhang

Group Chief Finance Officer

Zidong Zhang

Group Chief Finance Officer

Zidong Zhang is responsible for all aspects of financial management to support the growth of Novotech across Asia. Prior to joining Novotech, Dr. Zhang was CFO at Henlius Biotech, a Hong Kong-listed global biopharmaceutical company based in Shanghai, where he built and managed the finance team and played an integral role in the company’s initial public offering in 2019. Prior to that, Dr. Zhang was an equity research analyst at UBS in New York, where he covered the Major and Specialty Pharmaceutical Sector.

Barry Murphy

Barry Murphy

Chief Commercial Officer
Barry Murphy

Barry Murphy

Chief Commercial Officer

Barry joined in July 2014 to lead the growth of Novotech’s Business Development team. Barry started his career as a pharmacist having graduated from Trinity College Dublin. He began his clinical research career with ICON and worked in both Dublin and Sydney.

Andy Liu

Head of China

Andy Liu

Head of China

Andy worked at Covance, Inc., a global CRO, for more than 10 years in a number of executive positions. Most recently, he was General Manager of Covance's Central Laboratory Service, Asia Pacific, where he led a large multi-functional team of around 500 employees across multiple sites in APAC. Andy holds an MBA from the Booth School of Business at the University of Chicago, an MS in Electrical Engineering from the Rose-Hulman Institute of Technology, and a BS in Electrical Engineering from Tsinghua University.

Veronica Holloway

Veronica Holloway

Chief Legal and Compliance Officer
Veronica Holloway

Veronica Holloway

Chief Legal and Compliance Officer

Veronica joined Novotech in May 2014 to formalise the legal function at Novotech. Prior to Novotech, Veronica held roles as Senior Legal Counsel at EY, Senior Solicitor at Clayton Utz and General Counsel (on secondment) at Novartis Pharmaceuticals Australia Pty Limited. Veronica holds a BA/LLB/LLM.

Angela Edwardson

Angela Edwardson

Chief People Officer
Angela Edwardson

Angela Edwardson

Chief People Officer

Angela joined Novotech in November 2015 and is responsible for Novotech's Human Resources operations including strategy, organisational development, remuneration & reward and workplace health and safety. Angela is passionate about delivering Novotech's vision of being the leading CRO in the Asia Pacific region.